RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Amarillo, TX · Austin, TX · Bellaire, TX · +56 more sites
Clinical trials in Bellaire, TX
30 recruiting studies have a site in or near Bellaire, TX, Texas.
Top conditions here
- Obesity (6)
- Depression (5)
- Psoriasis (4)
- Rheumatoid Arthritis (4)
- Lupus (4)
- Crohn's Disease (3)
- Type 2 Diabetes (2)
- Migraine (2)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 30 of 30 studies
RecruitingPhase 3NCT07190209
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Sponsor: Sanofi
Allen, TX · Beaumont, TX · Bellaire, TX · +72 more sites
RecruitingPhase 3NCT07404865
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Sponsor: Vor Biopharma
Allen, TX · Amarillo, TX · +44 more sites
RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Bellaire, TX · El Paso, TX · Fort Worth, TX · +60 more sites
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites
RecruitingPhase 3NCT06671483
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Sponsor: Takeda
Baytown, TX · Bellaire, TX · +50 more sites
RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Bellaire, TX · League City, TX · Red Oak, TX · +22 more sites
RecruitingPhase 3NCT06307665
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor: AstraZeneca
Austin, TX · Baytown, TX · Beaumont, TX · +117 more sites
RecruitingPhase 3NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Bellaire, TX · Brownsville, TX · Corpus Christi, TX · +41 more sites
RecruitingPhase 3NCT07484217
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Sponsor: Axsome Therapeutics, Inc.
Austin, TX · Bellaire, TX · Dallas, TX · +37 more sites
RecruitingPhase 3NCT07621809
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sponsor: Novartis Pharmaceuticals
Bellaire, TX · Corpus Christi, TX · Euless, TX · +17 more sites
RecruitingPhase 2NCT07737743
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Sponsor: Novartis Pharmaceuticals
Allen, TX · Bellaire, TX · Corpus Christi, TX · +6 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Austin, TX · Bellaire, TX · Dallas, TX · +68 more sites
RecruitingPhase 2NCT07142356
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Sponsor: Retension Pharmaceuticals. Inc.
Bellaire, TX · Dallas, TX · Plano, TX · +31 more sites
RecruitingPhase 2NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Takeda
Bellaire, TX · Dallas, TX · Fort Worth, TX · +27 more sites
RecruitingPhase 3NCT06559306
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Sponsor: Janssen Research & Development, LLC
Austin, TX · Bellaire, TX · +81 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Austin, TX · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Austin, TX · +112 more sites
RecruitingPhase 3NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · +38 more sites
RecruitingPhase 3NCT07250802
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Sponsor: Takeda
Bellaire, TX · San Antonio, TX · +9 more sites
RecruitingPhase 3NCT07286058
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Sponsor: Takeda
Baytown, TX · Bellaire, TX · Houston, TX · +16 more sites
RecruitingPhase 4NCT06857942
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites
RecruitingPhase not listedNCT06725277
The OBSERVE Protocol
Sponsor: Yale University
Bellaire, TX · +7 more sites
RecruitingPhase 4NCT07611214
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Sponsor: Aurinia Pharmaceuticals Inc.
Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
RecruitingPhase 2NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Sponsor: Artiva Biotherapeutics, Inc.
Arlington, TX · Bellaire, TX · Irving, TX · +28 more sites
RecruitingPhase 3NCT07201129
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Sponsor: Viatris Innovation GmbH
Bellaire, TX · El Paso, TX · Houston, TX · +11 more sites
RecruitingPhase 3NCT04777357
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Sponsor: AbbVie
Austin, TX · Beaumont, TX · Bellaire, TX · +66 more sites
RecruitingPhase 3NCT07196501
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Sponsor: Neurocrine Biosciences
Austin, TX · Bellaire, TX · Friendswood, TX · +21 more sites
RecruitingPhase 2NCT06456593
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Sponsor: Abivax S.A.
Austin, TX · Baytown, TX · Bellaire, TX · +40 more sites
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Bellaire, TX · Dallas, TX · +52 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.